Insider Trading & Ownership of Stacy Lindborg

Location
Lawrenceville, NJ
Summary
The estimated net worth of Stacy Lindborg is at least $12,905 dollars as of 06 Jan 2026. Stacy Lindborg is the Director of BRAINSTORM CELL THERAPEUTICS INC. and owns shares of BRAINSTORM CELL THERAPEUTICS INC. (BCLI) stock worth about $11K. Stacy Lindborg is the President and CEO, Director of Imunon, Inc. and owns shares of Imunon, Inc. (IMNN) stock worth about $1.9K.
Signature
/s/ Susan Eylward, Attorney-in-Fact for Stacy Lindborg
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Stacy Lindborg and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.

Quick Takeaways

  • Stacy Lindborg has 2 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $12,905.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: BRAINSTORM CELL THERAPEUTICS INC. ($10,996).
  • Past-year value change for that position: .

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Source Evidence

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Stacy Lindborg

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
BCLI BRAINSTORM CELL THERAPEUTICS INC. Director $10,996 01 Jan 2025
IMNN Imunon, Inc. President and CEO, Director $1,909 02 Jan 2026

Insider Transactions Reported by Stacy Lindborg:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .